Guidelines for Stopping Mass Drug Administration and Verifying Elimination of Human Onchocerciasis: Criteria and Procedures
- PMID: 26913317
- Bookshelf ID: NBK344121
Guidelines for Stopping Mass Drug Administration and Verifying Elimination of Human Onchocerciasis: Criteria and Procedures
Excerpt
Following the publication of Guidelines on certification of elimination of human onchocerciasis in 2001 by the World Health Organization (WHO), these are the first evidence-based guidelines developed by NTD Department according to the international standards.
They provide a set of recommendations that would guide national programme managers in collaboration with their respective oversight committees on when to stop mass drug administration (MDA) and conduct post-treatment surveillance (PTS) activities for a minimum period of 3 to 5 year before confirming the interruption of transmission of Onchocerca volvulus parasite and hence its elimination.
They also include steps to undertake for verification of elimination of transmission of the parasite in the whole endemic country by the International Verification Team (IVT) prior to the official acknowledgement by WHO Director General.
Copyright © World Health Organization 2016.
Sections
- ACKNOWLEDGEMENTS
- GLOSSARY
- EXECUTIVE SUMMARY
- 1. BACKGROUND
- 2. RATIONALE
- 3. PURPOSE AND OBJECTIVES
- 4. TARGET AUDIENCE
- 5. METHODS
- 6. DECLARATION AND MANAGEMENT OF INTERESTS
- 7. RESULTS OF EVIDENCE RETRIEVAL, SYNTHESIS AND ASSESSMENT
- 8. RECOMMENDATIONS
- 9. STANDARD OPERATING PROCEDURES FOR STOPPING MDA AND VERIFYING ELIMINATION OF TRANSMISSION
- 10. POST-ELIMINATION SURVEILLANCE (PHASE 3)
- 11. FUTURE CONSIDERATIONS
- 12. DISSEMINATION AND EVALUATION OF THE EFFECT OF IMPLEMENTING THE GUIDELINES
- REFERENCES
- ANNEXES
Publication types
LinkOut - more resources
Full Text Sources